Related by context. All words. (Click for frequent words.) 71 MAGE A3 ASCI 69 APTIVUS r 69 efficacy tolerability 69 ritonavir boosted 68 CYT# potent vascular disrupting 68 CIMZIA ™ 68 plus prednisone prednisolone 68 tolerability profiles 68 metaglidasen 68 QTc prolongation 68 oral rivaroxaban 67 serum phosphorous 67 nab paclitaxel 67 erythropoietic 67 anti leukemic 67 bezafibrate 67 factor TNF 67 weekly subcutaneous injections 67 Tarceva TM 67 triglyceride lowering 67 limiting toxicity DLT 67 selective modulator 67 myopathy rhabdomyolysis 67 metformin sulfonylurea 67 oral prodrug 67 riociguat 67 uric acid lowering 67 novel VDA molecule 67 PREZISTA r 66 Vidaza azacitidine 66 visilizumab 66 adalimumab Humira 66 dose cohort 66 insulin sensitizing 66 aspirin clopidogrel 66 zonisamide SR 66 forodesine 66 cobiprostone 66 relapsed MM 66 pharmacodynamic PD 66 ZOLINZA 66 sorafenib tablets 66 HuMax EGFr 66 favorable pharmacokinetic profile 66 safety tolerability pharmacokinetic 66 Ceplene/IL-2 66 olmesartan 66 intravenous bisphosphonates 66 clomipramine 66 HMG CoA reductase inhibitors 66 alvespimycin 66 VAPRISOL 66 analgesic efficacy 66 ACTEMRA TM 66 secondary hyperparathyroidism 66 pharmacodynamic effects 66 rFVIIa 66 antiresorptive 66 pramlintide 66 tolerability pharmacokinetics 66 NATRECOR R 66 Pemetrexed 66 Oral NKTR 66 coadministration 66 fibrinolytic 65 pharmacokinetics pharmacodynamics 65 prokinetic agent 65 Teriflunomide 65 pharmacokinetic interactions 65 TNF Tumor Necrosis Factor 65 pharmacokinetics PK 65 alpha blocker 65 CA4P 65 CTAP# Capsules 65 alpha interferons 65 Triapine R 65 either acutely decompensated 65 gemifloxacin 65 liver transaminases 65 CIMZIA TM 65 Insulin PH# 65 serum triglyceride levels 65 severe gastroparesis 65 LAB CGRP 65 antithrombotic 65 peritumoral brain edema 65 clevidipine 65 pharmacodynamics PD 65 NATRECOR ® 65 colorectal adenoma 65 tamoxifen Nolvadex ® 65 ATACAND 65 aflibercept VEGF Trap 65 erlotinib Tarceva ® 65 MTP inhibitor 65 raloxifene Evista 65 PEGylated interferon beta 1a 65 IMiDs 65 Traficet EN 65 R Saizen R 65 SCH # 65 INVEGA ® 65 mertansine 65 mycophenolate mofetil 65 mapatumumab 65 antiarrhythmic 65 refractory gout 65 pharmacodynamic properties 65 Erythropoietic therapies may 65 AEGR 65 NIASPAN 65 refractory NSCLC 65 primary hypercholesterolemia 65 Enzastaurin 65 certolizumab 65 posaconazole 65 haematologic 65 rosuvastatin Crestor 65 canakinumab 65 angiotensin converting enzyme inhibitor 65 primidone 65 anti amnesic 65 galiximab 65 Tekamlo 65 6R BH4 65 CIMZIA TM certolizumab pegol 64 thalidomide Thalomid 64 overt nephropathy 64 hypercholesterolaemia 64 torsemide ER 64 β blockers 64 aminotransferases 64 pain palliation 64 Archexin 64 receptor tyrosine kinase inhibitor 64 glycosylated hemoglobin HbA1c 64 mitochondrial toxicity 64 desvenlafaxine succinate 64 TNF blocker therapy 64 Known hypersensitivity 64 statins cholesterol lowering 64 Natalizumab 64 orally administered inhibitor 64 ULORIC 64 relapsed myeloma 64 baminercept 64 pomalidomide 64 relapsed refractory multiple myeloma 64 endometrial hyperplasia 64 TPI ASM8 64 ARCALYST ® 64 IMiDs ® 64 HMG CoA reductase inhibitor 64 zolmitriptan 64 pharmacodynamic parameters 64 tibolone 64 TRPV1 agonist 64 LHRH agonist 64 Mg Uk 64 ALB # 64 potent antiproliferative 64 serum urate 64 NMDA antagonists 64 pharmacokinetic parameters 64 chemotherapy induced neutropenia 64 alkylating agent 64 CNS depressant 64 mTOR inhibitors 64 HCV protease inhibitors 64 Darusentan 64 Tasigna prolongs 64 clinically meaningful reductions 64 genotypic resistance 64 urinary N telopeptide 64 severe hypersensitivity reactions 64 Vaprisol 64 R lenalidomide 64 lesinurad 64 AST ALT 64 BEXXAR Therapeutic Regimen 64 anti arrhythmic 64 teriflunomide 64 overlapping toxicities 64 ALA PDT 64 VELCADE melphalan 64 thiazolidinedione TZD 64 ascending dose 64 rhIGF-I/rhIGFBP-3 64 thromboembolic disease 64 lenalidomide Revlimid R 64 Avandia Actos 64 Tolvaptan 64 anthracycline taxane 64 systemically administered 64 Phenoptin 64 Tß4 64 STRIDE PD 64 NMDA antagonist 64 plasma triglycerides 64 elevated serum creatinine 64 prednisone prednisolone 64 Aggrastat ® tirofiban hydrochloride 64 idarubicin 64 pulmonary exacerbations 64 FUSILEV enhances 64 LATUDA 64 INCB# [003] 64 Dual Opioid 64 aplindore 64 IMiDs R 64 dose colchicine 64 hematological parameters 64 flutamide 64 PSN# [002] 64 bardoxolone methyl 64 ARCOXIA 64 neovascular diseases 64 dosing frequency 64 hypercalcemia 64 lomitapide 64 antidiabetic drugs 64 CINQUIL 64 INSPIRE Trial Phase III 63 lipid lowering agents 63 unresectable HCC 63 BENICAR HCT 63 OMNARIS HFA 63 Ophena TM 63 AZILECT R 63 PXD# 63 hepatic enzymes 63 transaminase elevations 63 ZACTIMA 63 infusional 63 candesartan cilexetil 63 abacavir lamivudine 63 IMiDs ® compound 63 estramustine 63 motesanib 63 Histalean TM 63 Apoptone 63 thromboembolic events 63 pharmacodynamic profile 63 systemic hypotension 63 hepatotoxicity 63 malignancy HCM 63 anti resorptive 63 Bisphosphonate 63 midstage clinical 63 investigational humanized monoclonal antibody 63 INFERGEN 63 glycated hemoglobin levels 63 plasma renin activity 63 elevated ALT 63 elevated triglyceride levels 63 maximal doses 63 serum phosphate 63 biologic DMARD 63 pharmacodynamic 63 lenalidomide dexamethasone 63 inhaled iloprost 63 lipid altering 63 PRADAXA 63 adrenal suppression 63 TNF alpha inhibitor 63 PEG SN# 63 hyperphenylalaninemia HPA due 63 anticancer activity 63 idraparinux 63 CANCIDAS 63 TDF FTC 63 anti muscarinic 63 antidiabetic 63 budesonide foam 63 velafermin 63 pharmacokinetic characteristics 63 serum urate levels 63 CellCept mycophenolate mofetil 63 HER2 overexpression 63 oral antidiabetic 63 potent anticancer 63 investigational monoclonal antibody 63 salmeterol fluticasone 63 nalbuphine ER 63 aminotransferase levels 63 IAP inhibitor 63 intensive lipid lowering 63 trastuzumab Herceptin ® 63 neratinib 63 paclitaxel Taxol 63 paricalcitol 63 acadesine 63 tipifarnib 63 antiangiogenic therapy 63 rNAPc2 63 ACTOplus met XR 63 oral anti arrhythmic 63 5 lipoxygenase inhibitor 63 Primary endpoints 63 fenofibric acid 63 potassium sparing diuretics 63 vinca alkaloid 63 CYP#A# substrate 63 Fibrillex TM 63 immune modulating 63 concomitant medications 63 CorVue ™ 63 ISIS # 63 oral antidiabetic medication 63 antiplatelet 63 TRIOLEX HE# APOPTONE HE# 63 ritonavir boosted protease inhibitor 63 intravascular hemolysis 63 hematological toxicity 63 atazanavir ritonavir 63 Vectical 63 Zemplar Capsules 63 Hypotension 63 diarrhea predominant irritable 63 perampanel 63 Kinoid 63 ganetespib 63 Atrasentan 63 SILENOR 63 mercaptopurine 63 Tyrima 63 antifibrotic 63 dose proportionality 63 glomerular filtration 63 CR# vcMMAE 63 orally inhaled 63 MYCAMINE 63 catheter occlusion 63 Platinol ® cisplatin 63 isoproterenol 63 RG# ITMN 63 etanercept Enbrel 63 melphalan prednisone 63 aspartate aminotransferase AST 63 PAOD 63 pegylated liposomal doxorubicin 63 cisplatin gemcitabine 63 macrolide antibiotic 63 pyridostigmine 63 Octreolin 63 cilengitide 63 antihyperglycemic 63 Darapladib 63 metformin hydrochloride 63 pentoxifylline 63 sulodexide 63 FOLFOX chemotherapy 63 gemcitabine cisplatin 63 Intravitreal injections 63 #I TM# 63 crizotinib PF # 63 pegaptanib 63 safety tolerability pharmacokinetics 63 nasopharyngitis headache 63 ATL/TV# 63 Tolerability 63 PSMA ADC 63 plasma kallikrein inhibitor 63 prospectively stratified 63 alemtuzumab MS 63 liposomal formulation 63 uricase 63 hour bronchodilation 63 elevated LDL cholesterol 63 Eltrombopag 63 sargramostim 63 R#/MEM # 63 taxane resistant 63 renal toxicity 63 imexon 63 PLX STROKE targeting 63 Empatic 63 CG# [003] 63 SSRI SNRI 63 induce orthostatic hypotension 63 Cimzia TM 63 irbesartan 63 PREZISTA rtv 62 maximally tolerated lipid lowering 62 clinically meaningful improvements 62 eprotirome 62 fluticasone furoate 62 APTIVUS ritonavir 62 containing abacavir 62 achieved ACR# 62 Creatinine 62 potentially hepatotoxic 62 Aflibercept 62 antitumor effect 62 Selective Serotonin Reuptake Inhibitor 62 Sudhir Agrawal D.Phil 62 mecamylamine 62 Darinaparsin 62 albiglutide 62 oxycodone CR 62 cardiac toxicity 62 EGFR HER2 62 bronchial hyperresponsiveness 62 pathophysiological effects 62 PEGylated anti 62 recurrent glioblastoma multiforme 62 EXJADE 62 aripiprazole Abilify 62 headache nasopharyngitis 62 long acting beta2 62 RSD# oral 62 Dapagliflozin 62 hydroxymethyl coenzyme 62 receptor inhibitor 62 evaluating tivozanib 62 FOLFOX6 chemotherapy regimen 62 denileukin diftitox 62 febuxostat 62 aurora kinase 62 prulifloxacin 62 antithrombotic therapy 62 intravenously administered 62 pharmacodynamic markers 62 mg kg BID 62 TNF alpha antagonist 62 huC# DM4 62 angiotensin receptor blocker ARB 62 paroxetine sertraline 62 S/GSK# 62 Sitagliptin 62 multitargeted 62 LT NS# 62 endothelin antagonist 62 pamidronate 62 serum leptin 62 mg kg dose 62 basal bolus regimen 62 leukotriene receptor antagonist 62 cytoprotective 62 demonstrated antitumor activity 62 pegnivacogin 62 hsCRP levels 62 ruboxistaurin 62 endothelin receptor antagonists 62 Dabigatran etexilate 62 selective A2A adenosine receptor 62 Helicobacter pylori eradication 62 HQK 62 symptomatic paroxysmal AF 62 Triolex 62 anticoagulant warfarin 62 fluvastatin 62 vidofludimus 62 PPAR gamma agonist 62 Bezielle 62 ENMD # 62 rheumatoid arthritis osteoarthritis ankylosing 62 PNP inhibitor 62 systemic antifungal 62 KETEK 62 serum cortisol 62 postoperative ileus POI 62 parathyroid hormone PTH 62 cerebrovascular events 62 Cloretazine 62 Toxicities 62 insulin sensitizers 62 phase Ib 62 Navelbine ® 62 Lofexidine 62 oxypurinol 62 potent triglyceride lowering 62 FROVA 62 Golimumab 62 Q#IR 62 risperidone Risperdal 62 neuroprotective properties 62 lipid lowering 62 5 FU leucovorin 62 abiraterone acetate 62 favorable pharmacokinetic 62 transaminases 62 PI3K/Akt pathway inhibitor 62 statin monotherapy 62 lactate dehydrogenase LDH 62 hypervascular tumors 62 zileuton 62 MGd 62 pharmacokinetic profiles 62 xanthine oxidase inhibitor 62 Budesonide foam crofelemer 62 corticosteroid dose 62 steroid dexamethasone 62 CRx 62 intermittent dosing 62 PDX pralatrexate 62 prednisone prednisolone plus 62 prostanoid 62 pharmacologic stress 62 complement inhibitor eculizumab 62 quetiapine Seroquel 62 gemtuzumab ozogamicin 62 thromboxane A2 62 docetaxel chemotherapy 62 5 HT2A inverse 62 bronchodilatory 62 thiazolidinedione 62 BCG refractory carcinoma 62 systemic corticosteroid 62 pioglitazone HCl 62 telaprevir dosed 62 direct thrombin inhibitors 62 DU #b 62 Perforomist ™ Inhalation Solution 62 XP# XP# 62 angiotensin receptor blocker 62 venous thromboembolic disease 62 oral FTY# 62 avosentan 62 Seliciclib 62 adenoma recurrence 62 abnormal lipid 62 receiving VELCADE 62 Amrubicin 62 alagebrium 62 NB S# strontium malonate 62 nonnucleoside reverse transcriptase inhibitors 62 class mGluR5 inhibitor 62 acarbose 62 Telithromycin 62 elevated creatinine 62 HIV HCV coinfected 62 antidepressants fluoxetine 62 PegIntron 62 edifoligide 62 clobazam 62 Febrile neutropenia 62 vicriviroc 62 conventional DMARDs 62 pramlintide metreleptin combination 62 dose regimens 62 DITPA 62 somatostatin analogues 62 SinuNase TM 62 nadolol 62 rilonacept 62 PASI scores 62 hemostatic efficacy 62 non nucleoside HCV 62 serum aminotransferase levels 62 alfuzosin 62 calcineurin inhibitor 62 cannabinor 62 combinability 62 Akt activation 62 TG# [003] 62 antifibrinolytic 62 chronic thromboembolic pulmonary 62 acetonide FA 62 tiagabine 62 caspofungin 62 TAXUS VI 62 antineoplastic 62 dosage regimens 62 Pazopanib 62 hepatotoxic 62 anti androgen 62 lumiracoxib 62 PEGINTRON TM 62 pulmonary toxicity 62 mycophenolic acid 62 leukotriene receptor antagonists 62 solithromycin 62 TNFalpha 62 nucleoside analog 62 phase IIb study 62 HGS# 62 extrapyramidal symptoms 62 sitaxsentan 62 Doxil ® 62 antiangiogenic agents 62 heparanase 62 kidney urologic 62 antimuscarinic 62 OMP #M# 62 bupropion SR 62 KRN# 62 bone marrow suppression 62 Pioglitazone 62 rosuvastatin #mg 62 SPRYCEL ® 62 myeloperoxidase 62 TELINTRA 62 insulin degludec 62 opioid naïve 62 Tiotropium 62 ketoconazole 62 sorafenib Nexavar 62 Lipitor #mg 62 squalamine 62 bendamustine 62 adjunctive ABILIFY 62 R baclofen 62 dextromethorphan quinidine 62 mGluR5 NAM 62 thorough QT 62 inhaled budesonide 62 pertuzumab 62 atherogenic dyslipidemia 62 Carfilzomib 62 H2 antagonists 62 benazepril 62 tumor necrosis 62 targeted radiotherapeutic 62 Safinamide 62 Topiramate 62 CDK inhibitor 62 ZYBRESTAT fosbretabulin 62 Carvedilol 62 FASLODEX 62 TNF blocking 62 investigational pharmacologically unique 62 rufinamide 62 dyslipidemias 62 Pharmacokinetics PK 62 mild hepatic impairment 62 KRAS mutations occur 62 peripherally acting 62 SIMCOR 62 ancrod 62 endothelin antagonists 62 interferon gamma 1b 62 odanacatib 62 β blocker 62 VIIBRYD 62 efalizumab 62 Xanafide 62 microtubule targeting 62 Pimavanserin 62 simvastatin ezetimibe 61 adalimumab 61 romiplostim 61 GRNOPC1 contains 61 thrombin inhibiting aptamer 61 ß blockers 61 NOXAFIL Oral Suspension 61 temsirolimus 61 octreotide LAR 61 hematopoietic cancers 61 lipid parameters 61 morphometric vertebral fractures 61 serum uric acid sUA 61 Warfarin Coumadin 61 BAY #-# 61 Aclidinium 61 AVE# 61 ORENCIA ® 61 LibiGel ® 61 fluoropyrimidine 61 DACH platinum 61 relapsed multiple myeloma 61 mometasone 61 Xelox 61 oral antidiabetes 61 Lacosamide 61 nephrotoxicity 61 EDARBI 61 mixed hyperlipidemia 61 active comparator 61 IL 1ß 61 nicardipine 61 EFFEXOR XR 61 Panzem R 61 interferon alfa 2b 61 INC# 61 Paxil paroxetine 61 Androxal TM 61 Noxafil 61 ORENCIA R 61 DuraSite ® 61 thiazolidinediones TZDs 61 SNT MC# 61 bovine thrombin 61 Navelbine 61 glucose lowering 61 Panzem R NCD 61 non valvular atrial 61 aldosterone antagonist 61 QT QTc 61 PRISTIQ 61 Pyridorin 61 neuroleptic 61 ursodeoxycholic acid 61 #.#mg/dL 61 valsartan 61 regorafenib 61 GLPG# 61 vildagliptin 61 TAXOTERE R 61 preclinical efficacy 61 neutropenic sepsis 61 TH# [003] 61 Interferon beta 1a 61 Epanova 61 LEP ETU 61 tolvaptan 61 CYP#A# CYP#D# 61 SPIRIVA HandiHaler 61 NP2 Enkephalin 61 Cetrorelix pamoate 61 Apolipoprotein B 61 gastrointestinal toxicities 61 Pharmacokinetic studies 61 RoACTEMRA 61 inflammatory biomarkers 61 comparator arm 61 brand ciclesonide HFA 61 metformin accumulation 61 nonsteroidal 61 prostaglandin D2 61 D aspartate NMDA receptor 61 Genz # 61 Omacetaxine mepesuccinate 61 SNRI 61 doxorubicin cyclophosphamide 61 dose dexamethasone 61 LY# [003] 61 immunomodulating 61 #mg BID [003] 61 GnRH agonists 61 recurrent genital herpes 61 Vidaza ® 61 #mg/day [001] 61 CIMZIA R 61 Capesaris 61 GERD migraine headaches 61 eplerenone 61 HGS ETR1 mapatumumab 61 R sorafenib tablets 61 BoNTA 61 colesevelam HCl 61 INCB# [001] 61 neurologic progression 61 GAMMAGARD 61 ACAPODENE 61 APTIVUS 61 anthracycline chemotherapy 61 adriamycin 61 JAK inhibitor 61 opioid naive 61 prolonged QT interval 61 PKC# 61 lipid lowering therapies 61 ritonavir boosted atazanavir 61 hemodilution 61 PROMACTA 61 interferon IFN 61 Pramlintide 61 briakinumab 61 ALVESCO HFA 61 DMARDS 61 Diovan HCT 61 paroxetine Paxil 61 non constipating irritable 61 SGPT 61 reactogenicity 61 venlafaxine XR 61 INVANZ 61 monoamine oxidase inhibitors 61 laropiprant 61 pharmacologically active isomer 61 AAG geldanamycin analog 61 elotuzumab 61 Degarelix 61 subcutaneously administered 61 phase IIb trial 61 severe renal impairment 61 octreotide acetate 61 ribavirin therapy 61 SRT# [003] 61 cardiac repolarization 61 fosbretabulin 61 #mg/day [002] 61 Exelixis compounds 61 Inhaled nitric oxide 61 AZILECT 61 anti thrombotic 61 vinorelbine 61 convulsive disorders 61 teriparatide 61 serum potassium 61 Vascugel 61 BANZEL 61 N telopeptide 61 generation purine nucleoside 61 IFN beta 61 Dasatinib 61 AVANDIA 61 anaphylactic reactions bronchospasm 61 left ventricular diastolic 61 oral Hycamtin 61 plus gemcitabine 61 sweat chloride 61 Telik logo TELINTRA 61 elevated uric acid 61 MAP# 61 ZOMETA 61 eltrombopag 61 edoxaban 61 Cytogen marketed 61 dacetuzumab 61 topical calcineurin inhibitors 61 liposomal doxorubicin 61 TMS Therapy 61 Epratuzumab 61 chronic idiopathic thrombocytopenic purpura 61 AEG# 61 Zorbtive TM 61 Ambrisentan 61 Anti TNF 61 rosiglitazone maleate 61 dose escalation phase 61 FOSRENOL ® 61 aspartate aminotransferase 61 Thalomid ® 61 diarrhea vomiting nausea 61 ularitide 61 ALT flares 61 oral antidiabetic drugs 61 gefitinib Iressa 61 Panzem NCD 61 refractory CTCL 61 DOXIL 61 lanthanum carbonate 61 administered subcutaneously 61 TASKi3 61 thetreatment 61 bortezomib Velcade 61 TAXOTERE ® 61 HCD# [002] 61 Glypromate 61 inhibit platelet function 61 phosphate binding 61 DFMO 61 panitumumab Vectibix 61 1mg dose 61 mycophenolate mofetil MMF 61 ULTRAM ER 61 CYP#D# inhibitor 61 invasive candidiasis 61 somatostatin analog 61 oxymorphone ER 61 diabetic gastroparesis 61 AGILECT R 61 prucalopride 61 tapentadol ER 61 SomatoKine R 61 LMWH 61 COPEGUS therapy 61 MoxDuo IR 61 Edarbi 61 retinal vein occlusion induced 61 Mipomersen 61 Effexor venlafaxine 61 mg BID dose 61 dosing cohort 61 plus methotrexate 61 glycated hemoglobin HbA1c 61 mg TID 61 severe exacerbations 61 piroxicam 61 baseline A1C 61 PEG PAL 61 acromegalic patients 61 PSA nadir 61 pegylated IFN 61 BENLYSTA ® 61 kilogram mg kg 61 cardiotoxic 61 Methylnaltrexone 61 oral talactoferrin 61 doxepin HCl 61 hepatic enzyme 61 antiemetics 61 achieved statistical significance 61 Hepatotoxicity 61 AA Amyloidosis 61 ZD# [001] 61 ibandronate 61 insulin detemir 61 dasatinib Sprycel 61 glitazone 61 inhaled corticosteroid ICS 61 tumor lysis syndrome 61 ALT AST 61 Cardiotoxicity 61 anti fibrotic 61 intravenous cyclophosphamide 61 serotonin neurotransmission 61 NPH insulin 61 constipation predominant irritable bowel 61 salmeterol inhalation powder 61 related hematological toxicity 61 intravesical 61 mixed dyslipidemia 61 urocortin 2 61 phosphodiesterase inhibitors 61 Silodosin 61 INTEGRILIN ® 61 ® lenalidomide 61 vorinostat 61 antihypertensive therapy 61 deferiprone 61 adenosine injection 61 antiarrhythmic drug 61 4mg/kg 61 alefacept 61 IV Busulfex 61 H2 blocker 61 naïve HCV 61 ALN HPN 61 Solulin 61 MEVACOR 61 trospium 61 NOXAFIL 61 urinary calcium 61 oral methylnaltrexone 61 RAS blockers 61 Protelos 61 fusion enhancers 61 alanine aminotransferase 61 atorvastatin #mg 61 E2F Decoy 61 2A receptor agonist 61 inverse agonist 61 OMS# 61 symptomatic intracranial hemorrhage 61 C1 INH 61 alvimopan 61 dose corticosteroids 61 metreleptin 61 dasatinib Sprycel ® 61 K ras mutations 61 SomatoKine 61 Phase 2b clinical trials 61 Zenvia ™ 61 Aprotinin 61 glycopyrrolate 61 thromboembolic 61 selective antagonist 61 oral Janus kinase 61 Neulasta ® 61 maximally tolerated dose 61 Afatinib 61 GRNCM1 61 leflunomide 61 iroxanadine 61 flecainide 61 schizophrenia CIAS 61 hematologic toxicity 61 QTc intervals 61 Gabapentin GR 61 brivaracetam 61 guanfacine 61 maximal tolerated 61 haloperidol Haldol 61 beclomethasone dipropionate 61 gemcitabine Gemzar 61 RH1 61 viral kinetic 61 oral antiviral 61 YONDELIS 61 Empatic ™ 61 Omacetaxine 61 myeloproliferative diseases 61 dexamethasone Decadron 61 antiangiogenic activity 61 davalintide 61 viral kinetics 61 multicenter Phase II 61 Cytoxan 61 substrates inhibitors 61 recurrent metastatic ovarian cancer 61 PrevOnco ™ 61 CYT# QbG# 61 PRT# 61 Celebrex celecoxib 60 Lp PLA 2 60 naltrexone hydrochloride 60 Non inferiority 60 CXB# 60 Entereg R 60 HeFH 60 Selzentry Celsentri 60 hemoglobin A1c HbA1c 60 amprenavir 60 EEG abnormalities 60 Pertuzumab 60 Apidra ®